Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

Journal of Clinical Investigation

Volumn 103, Issue 6, 1999, Pages 779-788

  Zhu, Zhou ^a   Homer, Robert J ^a,b   Wang, Zhonde ^a   Chen, Qingsheng ^a   Geba, Gregory P ^a,c   Wang, Jingming ^a   Zhang, Yong ^a   Elias, Jack A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Erck and Company Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; INTERLEUKIN 13; MESSENGER RNA;

AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FIBROSIS; INFLAMMATION; LUNG DISEASE; MOUSE; MUCUS SECRETION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; RNA ANALYSIS;

EID: 0033560126     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5909     Document Type: Article

References (71)

1. Lucey, D.R., Clerici, M., and Shearer, G.M. 1996. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases [review]. Clin. Microbiol. Rev. 9:532-562.
2. Abbas, A.K., Murphy, K.M., and Sher, A. 1996. Functional diversity of helper T lymphocytes. Nature. 383:787-793.
3. Mosmann, T.R., and Sad, S. 1996. The expanding universe of T-cell sub-sets: Th1, Th2 and more. Immunol. Today. 17:138-146.
4. Moller, D.R., et al. 1996. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J. Immunol. 156:4952-4960.
5. Barner, M., Mohrs, M., Brombacher, F., and Kopf, M. 1998. Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr. Biol. 8:669-672.
6. Huffnagle, G.B., Boyd, M.B., Street, N.E., and Lipscomb, M.F. 1998. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J. Immunol. 160:2393-2400.
7. McKenzie, G.J., Bancroft, A., Grencis, R.K., and McKenzie, A.N. 1998. A distinct role for interleukin-13 in Th2-cell- mediated immune responses. Curr. Biol. 8:339-342.
8. Robinson, D.S., et al. 1992. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
9. Kopf, M., et al. 1996. IL-5-deficient mice have a developmental defect in CD5 B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 4:15-24.
10. Foster, P.S., Hogan, S.P., Ramsay, A.J., Matthaei, K.I., and Young, I.G. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
11. Nakajima, H., et al. 1992. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am. Rev. Respir. Dis. 146:374-377.
12. Mould, A.W., Matthaei, K.I., Young, I.G., and Foster, P.S. 1997. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1064-1071.
13. Yamaguchi, Y., et al. 1988. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J. Exp. Med. 167:1737-1742.
14. Corry, D.B., et al. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109-117.
15. Lopez, A.F., et al. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219-224.
16. Clutterbuck, E.J., Hirst, E.M., and Sanderson, C.J. 1989. Human interleukin 5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparisons and interactions with IL-1, IL-3, IL-6 and GM-CSF. Blood. 73:1504-1512.
17. Cohn, L., Homer, R.J., Marinov, A., Rankin, J., and Bottomly, K. 1997. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186:1737-1747.
18. Cohn, L., Tepper, J.S., and Bottomly, K. 1998. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J. Immunol. 161:3813-3816.
19. Hogan, S. P., et al. 1998. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J. Immunol. 161:1501-1509.
20. Holgate, S.T., Wilson, J.R., and Howarth, P.H. 1992. New insights into airway inflammation by endobronchial biopsy. Am. Rev. Respir. Dis. 145:2s-6s.
21. Kim, K.C., et al. 1997. Airway goblet cell mucin: its structure and regulation of secretion. Eur. Respir. J. 10:2644-2649.
22. Bradding, P., Redington, A.E., and Holgate, S.T. 1997. Airway wall remodelling in the pathogenesis of asthma: cytokine expression in the airways. In Airway wall remodelling in asthma. A.G. Stewart, editor. CRC Press. Boca Raton, FL. 29-63.
23. Roche, W.R., Williams, J.H., Beasley, R., and Holgate, S.T. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1:520-524.
24. Weinberger, S. 1993. Recent advances in pulmonary medicine. N. Engl. J. Med. 328:1389-1397.
25. Whyte, M.K.B., Choudry, N.B., and Ind, P.W. 1993. Bronchial hyperresponsiveness in patients recovering from acute severe asthma. Respir. Med. 87:29-35.
26. Pueringer, R.J., and Hunninghake, G.W. 1992. Inflammation of airway reactivity in asthma. Am. J. Med. 92:32-38.
27. Robinson, D., et al. 1993. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92:313-324.
28. de Vries, J.E. 1998. The role of IL-13 and its receptor in allergy and inflammatory responses. J. Allergy Clin. Immunol. 102:165-169.
29. Minty, A., et al. 1997. The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. Eur. Cytokine Netw. 8:203-213.
30. Emson, C.L., Bell, S.L., Jones, A., Wisden, W., and McKenzie, A.N.J. 1998. Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J. Exp. Med. 188:399-404.
31. Zurawski, G., and de Vries, J.E. 1994. Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today. 15:19-26.
32. Bochner, B.S., Klunk, D.A., Sterbinsky, S.A., Coffman, R.L., and Schleimer, R.P. 1995. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J. Immunol. 154:799-803.
33. Murata, T., Obiri, N.I., and Puri, R.K. 1998. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors [review]. Int. J. Mol. Med. 1:551-557.
34. Sornasse, T., Larenas, P.V., Davis, K.A., de Vries, J.E., and Yssel, H. 1996. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J. Exp. Med. 184:473-483.
35. Endo, T., Ogushi, F., Kawano, T., and Sone, S. 1998. Comparison of the regulation by Th2-type cytokines of the atachidonic-acid metabolic pathway in human alveolar macrophages and monocytes. Am. J. Respir. Cell Mol. Biol 19:300-307.
36. Yu, C.R., Kirken, R.A., Malabarba, M.G., Young, H.A., and Ortaldo, J.R. 1998. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. J. Immunol. 161:218-227.
37. Zund, G., Madera, J.L., Dzus, A.L., Awtrey, C.S., and Colgan, S.P. 1996. Interleukin-4 and interleukin 13 differentially regulate epithelial chloride secretion. J. Biol. Chem. 271:7460-7464.
38. Horie, S., et al. 1997. Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. Intern. Med. 36:179-185.
39. Jung, T., Wijdenes, J., Neumann, C., de Vries, J.E., and Yssel, H. 1996. Interleukin-13 is produced by activated CD45RA+ and CD45R0+ T cells: modulation by interleukin-4 and interleukin-12. Eur. J. Immunol. 26:571-577.
40. Kaser, A., Molnar, C., and Tilg, H. 1998. Differential regulation of interleukin 4 and interleukin 13 production by interferon alpha. Cytokine. 10:75-81.
41. Humbert, M., et al. 1997. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J. Allergy Clin. Immunol. 99:657-665.
42. Kotsimbos, T.C., Ernst, P., and Hamid, Q.A. 1996. Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. Proc. Assoc. Am. Physicians. 108:368-373.
43. Huang, S.K., et al. 1995. IL-13 expression at the sites of allergen challenge in patients with asthma. J. Immunol. 155:2688-2694.
44. Akdis, M., Akdis, C.A., Weigl, L., Disch, R., and Blaser, K. 1997. Skinhoming, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA-memory T cells. J. Immunol. 159:4611-4619.
45. Katagiri, K., Itami, S., Hatano, Y., and Takayasu, S. 1997. Increased levels of IL-13 mRNA, but not IL-4 mRNA, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis (AD). Clin. Exp. Immunol. 108:289-294.
46. Pawankar, R.U., et al. 1995. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am. J. Respir. Crit. Care Med. 152:2059-2067.
47. Hamilos, D.L., et al. 1996. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am. J. Respir. Cell Mol. Biol. 15:433-450.
48. Chensue, S.W., Warmington, K., Ruth, J.H., Lukacs, N., and Kunkel, S.L. 1997. Myobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokineandchemokine networks. J. Immunol. 159:3565-3573.
49. Zhang, D.H., Cohn, L., Ray, P., Bottomly, K., and Ray, A. 1997. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272:21597-21603.
50. Tang, W., et al. 1996. Targeted expression of IL-11 in the murine airway causes airways obstruction, bronchial remodeling and lymphocytic inflammation. J Clin. Invest. 98:2845-2853.
51. Pack, R.J., Al-Ugaily, L.H., and Morris, G. 1981. The cells of the tracheobronchial epithelium of the mouse: a quantitative light and electron microscope study. J. Anat. 132:71-84.
52. Ray, P., et al. 1997. Regulated overexpression of interleukin-11 in the lung: use to dissociate development-dependent and -independent phenotypes. J. Clin. Invest. 100:2501-2511.
53. Stripp, B.R., et al. 1992. Cis-acting elements that confer lung epithelial cell expression of the CC10 gene. J. Biol. Chem. 267:14703-14712.
54. Hogan, B., Constantini, F., and Lacy, E. 1986. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY. 1-332.
55. Elias, J.A., et al. 1994. Epithelial interleukin-11: regulation by cytokines, respiratory syncytial virus and retinoic acid. J. Biol. Chem. 169:22261-22268.
56. Hamelmann, E., et al. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care. Med. 156:766-775.
57. Kline, J.N., et al. 1998. Cutting edge: modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160:2555-2559.
58. DiCosmo, B.F., et al. 1994. Airway targeted incerleukin-6 in transgenic mice: uncoupling of airway inflammation and bronchial hyperreactivity. J. Clin. Invest. 94:2028-2035.
59. Temann, U.A., et al. 1997. A novel role for murine IL-4 in vivo: induction of MU5AC gene expression and mucin hypersecrerion. Am. J. Respir. Cell Mol. Biol. 16:471-478.
60. Gupta, P.K. 1998. Pulmonary cytopathology. In Fishman's pulmonary diseases and disorders. 3rd ed. A.P. Fishman et al., editors. McGraw-Hill, New York, NY. 487-504.
61. Hosken, N.A., Shibuya, K., Heath, A.W., Murphy, K.M., and O'Garra, A. 1995. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-α-transgenic model. J. Exp. Med. 182:1579-1584.
62. Rogge, L., et al. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825-831.
63. Rankin, J.A., et al. 1996. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreacrivity. Proc. Natl. Acad. Sci. USA. 93:7821-7825.
64. DeFife, K.M. 1997. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J. Immunol. 158:3385-3390.
65. Hancock, A., Armstrong, L., Gama, R., and Millar, A. 1998. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am. J. Respir. Cell. Mol. Biol. 18:60-65.
66. Jain-Vora, S., Wert, S.E., Temann, U.-A., Rankin, J.A., and Whitsett, J.A. 1997. Interleukin-4 alters epithelial cell differentiation and surfactant homeostasis in the postnatal mouse lung. Am. J. Respir. Cell Mol. Biol. 17:541-551.
67. Hasegawa, M., Fujimoto, M., Kikuchi, K., and Takehara, K. 1997. Elevated serum levels of interleukin 4 (IL-4) IL-10, and IL-13 in patients with systemic sclerosis. J. Rheumatol. 24:328-332.
68. Gonzalo, J.-A., et al. 1998. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsivness. J. Exp. Med. 188:157-167.
69. Jose, P.J., et al. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J. Exp. Med. 179:881-887.
70. Matthews, A.N., et al. 1998. Eotaxin is required for the baseline level of tissue eosinophils. Proc. Natl. Acad. Sci. USA. 95:6273-6278.
71. Rothenberg, M.E., et al. 1996. Eotaxin triggers eosinophil selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin-5 in mice. Mol. Med. 2:334-348.